VRC-MALMAB0100-00-AB

N/A

Report date: 2022/07/13 16:45:44

Base Information

Drug NameVRC-MALMAB0100-00-AB
Drug Alias NameCIS43LSVRC-MALMAB0100-00-ABVRC-MALMAB-0100-00-ABCIS-43-LS
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Circumsporozoite protein
TargetsCircumsporozoite protein
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMali
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A